tim.hodson
Tue, 07/29/2025 – 14:33
July 23, 2025 — Elekta has received U.S. Food and Drug Administration (FDA) 510(k) clearance to include refractory, intractable mesial temporal lobe epilepsy (MTLE) in adults among its indications for use with the company’s Leksell Gamma Knife radiosurgery system.
Intractable epilepsy, also known as drug-resistant epilepsy, is a form of the disease in which a person’s seizures cannot be controlled with medication. Gamma Knife surgery treats refrac…